Evidence map›Paper›PMID 35284621›Full record

ArticleInformatics in medicine unlocked2022

A stochastic process based modular tool-box for simulating COVID-19 infection spread.

S S Manathunga, I A Abeyagunawardena, S D Dharmaratne

Abstract read
In one paragraph

Article in Informatics in medicine unlocked, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S S ManathungaNational Hospital of Sri Lanka, Sri Lanka.
I A AbeyagunawardenaNational Hospital of Sri Lanka, Home Address- 155, George E De Silva Mawatha, Kandy, Sri Lanka.
S D DharmaratneDepartment of Community Medicine, Faculty of Medicine, University of Peradeniya, Sri Lanka, Institute for Health Metrics and Evaluation, Department of Health Metrics Sciences, School of Medicine, University of Washington, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The novel coronavirus disease (COVID-19) culminated in a pandemic with many countries affected in varying stages. We aimed to develop a simulation environment for COVID-19 spread, taking environmental and social factors into account. Methods: The program was written in R language. A stochastic point process simulation model for simulating epidemics, a maximum-likelihood estimation model, an exponential growth rate model for calculating the basic reproduction number (R0), and functions for generating graphical representations of the simulations were utilized.Geographical area definition, population size, the number of initial infected individuals, period of simulation, parameters accounting for the radius of spread like masks usage, mobility level, intrinsic viral virulence, average infectious period, fraction of population vaccinated, time of vaccination, the efficacy of the vaccine, presence or absence of quarantine centers, time of establishment of quarantine centers, the efficacy of case detection and average time to quarantine from the detection of the infection were considered. Results: When the defined parameters were input, the model performed successfully producing the epidemic curve, R0 and an animation of infection spread. It was found that when parameters of known epidemics such as COVID-19 in California, Texas and, Florida were input, the epidemic curve generated was comparable to the epidemic curve in reality. Conclusion: This model can be utilized by many countries to visualize the effects of various mitigation strategies applied in their stage of disease and for policy makers to make informed decisions. It is applicable to many infectious diseases and hence can be used for research and educational purposes.

Indexed as

CoronavirusCOVID-19COVID-19 simulationDisease modeling

Identifiers

PMID35284621
PMCPMC8897234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.